Ventria Bioscience is the first company to commercialize recombinant proteins derived from a plant-based manufacturing system. These products are being developed as human therapeutics and as bioreagents to improve biomanufacturing.
Ventria’s technology platform ExpressTec is a safe, affordable and sustainable manufacturing technology that achieves recombinant protein yield that is many times higher than alternative systems. This advantage means Ventria’s products are accessible to a global customer base. For more information see www.Ventria.com
InVitria is a Division of Ventria Bioscience that develops and markets products used globally to improve productivity, consistency and safety of biopharmaceuticals, cellular therapies, regenerative medicines, medical devices and diagnostics. See www.InVitria.com
Ventria Bioscience Address
2718 Industrial Drive Junction City, KS United States